Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
- PMID: 32555425
- DOI: 10.1038/s41591-020-0978-1
Publisher Correction: Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis
Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Erratum for
- 
  
  Single-arm, open-label phase 2 trial of pembrolizumab in patients with leptomeningeal carcinomatosis.Nat Med. 2020 Aug;26(8):1280-1284. doi: 10.1038/s41591-020-0918-0. Epub 2020 Jun 2. Nat Med. 2020. PMID: 32483359 Clinical Trial.
Publication types
LinkOut - more resources
- Full Text Sources
 
        